Samik Pharmaceutical Company LTD.
Research Samik Pharmaceutical Company LTD. (014950.KQ) on Bullrun: market cap KRW 80.34B, dividend yield 0.5%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker014950.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryBiotechnology
- CurrencyKRW
- Market capKRW 80.34B
- Dividend yield0.5%
- Financial periodQ2 2026
- RevenueKRW 15.70B
- Net income-KRW 77.46M
- Free cash flowKRW 369.74M
- Gross margin67.0%
Valuation Snapshot
latest market cap is KRW 80.34B; dividend yield is 0.5%.
Peer valuation comparison
Latest dividend yield is 0.5% versus a Healthcare sector median of 2.4% (79.2% below).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 80.34B | n/a | 0.5% | 40 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 40 KRW, yield 0.5%.
About Samik Pharmaceutical Company LTD.
Samik Pharmaceutical Company LTD. develops and manufactures pharmaceuticals. The company offers oral therapeutic pharmaceuticals. It also provides drug compounds, drug delivery systems, drug repositioning, and reinforcement of biopharmaceuticals. The company was founded in 1973 and is based in Seoul, South Korea.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Samik Pharmaceutical Company LTD.'s market cap?
Samik Pharmaceutical Company LTD.'s market capitalization is KRW 80.34B.
Does Samik Pharmaceutical Company LTD. pay a dividend?
Samik Pharmaceutical Company LTD. has a dividend yield of 0.5%.
What does Samik Pharmaceutical Company LTD. do?
Samik Pharmaceutical Company LTD. develops and manufactures pharmaceuticals. The company offers oral therapeutic pharmaceuticals. It also provides drug compounds, drug delivery systems, drug repositioning, and reinforcement of biopharmaceuticals. The company was founded in 1973 and is based in Seoul, South Korea.